Skip to content
DataLookout
Menu

NCT07439315

The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 1 year 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jun 1, 2026 to Sep 1, 2027 Show 4 more changesShow less
    • Start date: Mar 1, 2026 to Jan 1, 2027
    • Eligibility criteria expanded, about 23 words
    • Study completion pushed from Aug 1, 2026 to Dec 1, 2027
    • Publications: details revised at 25 of 28 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Knee Injury and Osteoarthritis Outcome Score (KOOS)
Timeframe: Baseline, 2, 4, 8, 12 weeks
European Quality of Life-5 Dimensions (EQ-5D-5L)
Timeframe: Baseline, 2, 4, 8, 12 weeks.
Visual Analogue Scale (VAS)
Timeframe: Baseline, 2, 4, 8, 12 weeks.
Functional Mobility Assessments
Timeframe: Baseline, 2, 4, 8, 12 weeks
Functional Mobility Assessment
Timeframe: Baseline, 2, 4, 8, 12 weeks

Arms and interventions

The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee OsteoarthritisExperimental

Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for 12 weeks and document how often they wear the brace and their pain scores. Patients will fill out outcome surveys at 2, 4, 6, 8, and 12 weeks.

Devices: Medial joint distraction brace

Sites

1 site in 1 country

  • Icarus Medical InnovationsCharlottesville, Virginia, United States